A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma

A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma

Bibliographic Details
Main Authors:	Emily Zhou, Baoyi Zhang, Kenneth Zhu, Evelien Schaafsma, Runjun D. Kumar, Chao Cheng
Format:	Article
Language:	English
Published:	Wiley 2020-12-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.216

Similar Items

Overexpression of truncated ERG from TMPRSS2-ERG fusion and prostate cancer development
by: Melanie Leong, et al.
Published: (2009-09-01)

Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
by: Scott A. Tomlins, et al.
Published: (2008-02-01)

5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancer.
by: Francesca Zammarchi, et al.
Published: (2013-01-01)

TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.
by: Christina Hägglöf, et al.
Published: (2014-01-01)

Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
by: Manuela Krumbholz, et al.
Published: (2019-01-01)

Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2021-06-01)

Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer
by: Jae Won Yun, et al.
Published: (2021-05-01)

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
by: Francesca Giunchi, et al.
Published: (2020-12-01)

TMPRSS2: ERG expression in prostate cancer: Imaging and clinico-pathological correlations
by: V. Fasulo, et al.
Published: (2020-10-01)

PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
by: Jack A. Schalken, et al.
Published: (2010-07-01)

Study of the mechanisms causing the TMPRSS2:ERG gene fusion in prostate cancer
by: Coll Bastus, Nuria
Published: (2013)

Detection of tmprss2-erg and tmprss2-egr1 gene fusion in prostate cancer from a Chinese population
by: Changqing Xu, et al.
Published: (2020-12-01)

Noninvasive Detection of TMPRSS2:ERG Fusion Transcripts in the Urine of Men with Prostate Cancer
by: Bharathi Laxman, et al.
Published: (2006-10-01)

Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations
by: Laura E Pascal, et al.
Published: (2016-01-01)

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer.
by: Giorgia Urbinati, et al.
Published: (2015-01-01)

Diagnostic value of PCA3, TMPRSS2:ERG and prostatic specific antigen derivatives in the detection of prostate cancer
by: A. A. Musaelyan, et al.
Published: (2020-07-01)

Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
by: Lucile Tallon, et al.
Published: (2014-07-01)

TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN Lesions
by: Nuno Cerveira, et al.
Published: (2006-10-01)

Whole Transcriptome Analysis Reveals Established and Novel Associations with TMPRSS2:ERG Fusion in Prostate Cancer
by: Chow, Anthony
Published: (2012)

Whole Transcriptome Analysis Reveals Established and Novel Associations with TMPRSS2:ERG Fusion in Prostate Cancer
by: Chow, Anthony
Published: (2012)

<it>TMPRSS2-ERG </it>-specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
by: Brase Jan C, et al.
Published: (2011-12-01)

The Role of AMACR, CD10, TMPRSS2-ERG, and p27 Protein Expression Among Different Gleason Grades of Prostatic Adenocarcinoma on Needle Biopsy
by: Özdemir Gülhan, et al.
Published: (2020-08-01)

BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
by: Xiangyi Li, et al.
Published: (2018-01-01)

Status of TMPRSS2–ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism
by: Aparna Bhanushali, et al.
Published: (2018-12-01)

EXPRESSION OF ERG IMMUNOHISTOCHEMICAL STAIN IN PROSTATIC ADENOCARCINOMA
by: Sana Ghulam Nabi, et al.
Published: (2021-06-01)

Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status
by: Ilona Dudka, et al.
Published: (2020-05-01)

SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo
by: Carlos D. Cruz-Hernández, et al.
Published: (2020-07-01)

Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer.
by: Longjiang Shao, et al.
Published: (2013-01-01)

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
by: Kluth M, et al.
Published: (2018-11-01)

Molecular Characterization and Clinical Impact of TMPRSS2-ERG Rearrangement on Prostate Cancer: Comparison between FISH and RT-PCR
by: A. Fernández-Serra, et al.
Published: (2013-01-01)

EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
by: Marita Zoma, et al.
Published: (2021-07-01)

Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.
by: Lihong Yin, et al.
Published: (2011-01-01)

ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance
by: Atif Ali Hashmi, et al.
Published: (2019-01-01)

Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene.
by: Franclim R Ribeiro, et al.
Published: (2011-01-01)

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
by: Christoph Fraune, et al.
Published: (2020-03-01)

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status
by: Caterina Mancarella, et al.
Published: (2017-05-01)

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
by: Gleave Martin E, et al.
Published: (2008-08-01)

Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with Rearrangement
by: Maisa Yoshimoto, et al.
Published: (2006-06-01)

TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.
by: Orit Leshem, et al.
Published: (2011-01-01)

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
by: Louie Semaan, et al.
Published: (2019-10-01)